Long‐Term Outcomes Among Lung Transplant Recipients With High‐Risk Cytomegalovirus Mismatch Managed With a Multimodality Regimen
A proactive multimodality CMV management protocol consisting of antiviral agents (ganciclovir/valganciclovir) and immune augmentation with CMV immune globulin may improve outcomes among high-risk CMV mismatch LT recipients.
Authors
- Adrian Lawrence
- Natasha Banga (ORCID: https://orcid.org/0000-0002-9399-6884)
- Rohan Kanade
- Vaidehi Kaza
- Fernando Torres (ORCID: https://orcid.org/0000-0002-9587-010X)
- I. Timofte
- Srinivas Bollineni
- Anishka Kappalayil
Institutions
- Southwestern Medical Center (US)
- The University of Texas Southwestern Medical Center (US)
Publication Details
- Journal
- Clinical Transplantation
- Published
- 2025-06-30
- DOI
- https://doi.org/10.1111/ctr.70219
- Citations
- 2
- Primary Topic
- Cytomegalovirus and herpesvirus research
- Type
- article
- Field-Weighted Citation Impact
- 2.71